Type 2 Diabetes

Showing NaN - NaN of 51

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Type 2 Diabetes Trial in Worldwide (ITCA 650 60 mcg/day, sitagliptin)

Completed
  • Type 2 Diabetes
  • Birmingham, Alabama
  • +53 more
May 13, 2016

Type 2 Diabetes, Obesity, Diabesity Trial in Birmingham, Glasgow, London (Liraglutide, Duodenal-jejunal bypass liner -

Unknown status
  • Type 2 Diabetes
  • +2 more
  • Liraglutide
  • Duodenal-jejunal bypass liner - Endobarrier device
  • Birmingham, United Kingdom
  • +3 more
Apr 25, 2016

Type 2 Diabetes Trial in Worldwide (Saxagliptin, Dapagliflozin, Metformin IR)

Completed
  • Type 2 Diabetes
  • Birmingham, Alabama
  • +83 more
Mar 24, 2016

Type 2 Diabetes, Cardiovascular Disease Trial in Worldwide (TAK-875, TAK-875 Placebo)

Terminated
  • Type 2 Diabetes
  • Cardiovascular Disease
  • Birmingham, Alabama
  • +587 more
Oct 15, 2015

Type 2 Diabetes Trial in United States (ITCA 650, ITCA )

Completed
  • Type 2 Diabetes
  • ITCA 650
  • ITCA placebo
  • Birmingham, Alabama
  • +121 more
Jul 28, 2015

Type 2 Diabetes Trial in Worldwide (Saxagliptin, 5 mg + insulin, Placebo + insulin)

Completed
  • Type 2 Diabetes
  • Saxagliptin, 5 mg + insulin
  • Placebo + insulin
  • Tempe, Arizona
  • +79 more
May 8, 2015

Type 2 Diabetes, Hypogonadism Trial in United States (Androgel (testosterone gel))

Completed
  • Type 2 Diabetes
  • Hypogonadism
  • Androgel (testosterone gel)
  • Birmingham, Alabama
  • +69 more
Jan 19, 2015

A 2-Month Safety Follow-Up Trial

Completed
  • Type 1 Diabetes
  • Type 2 Diabetes
  • Birmingham, Alabama
  • +149 more
Dec 1, 2014

Type 2 Diabetes, Overweight, Obesity Trial in United States (Weight Watchers modified program, Standard Care group)

Completed
  • Type 2 Diabetes
  • +2 more
  • Weight Watchers modified program
  • Standard Care group
  • Birmingham, Alabama
  • +14 more
Oct 14, 2014

Type 2 Diabetes Trial in Worldwide (KRP-104, Placebo)

Completed
  • Type 2 Diabetes
  • Birmingham, Alabama
  • +45 more
Jun 23, 2014

Chronic Periodontitis, Type 2 Diabetes Trial in United States (Non-surgical periodontal therapy, Delayed non-surgical

Completed
  • Chronic Periodontitis
  • Type 2 Diabetes
  • Non-surgical periodontal therapy
  • Delayed non-surgical periodontal therapy
  • Birmingham, Alabama
  • +7 more
Jan 17, 2014

Type 2 Diabetes Trial in Worldwide (Dapagliflozin, Placebo)

Completed
  • Type 2 Diabetes
  • Fresno, California
  • +95 more
Sep 25, 2013

Obesity, Type 2 Diabetes Trial in United States (VI-0521)

Completed
  • Obesity
  • Type 2 Diabetes
  • Birmingham, Alabama
  • +5 more
Sep 5, 2012

Chronic Kidney Disease, Type 2 Diabetes, Diabetic Nephropathy Trial in United States (Placebo, Bardoxolone Methyl (RTA 402))

Completed
  • Chronic Kidney Disease
  • +2 more
  • Placebo
  • Bardoxolone Methyl (RTA 402)
  • Birmingham, Alabama
  • +41 more
Jun 12, 2012

Type 2 Diabetes Trial in Worldwide (Lapaquistat acetate and lipid-lowering therapy, Lipid-lowering therapy)

Completed
  • Type 2 Diabetes
  • Lapaquistat acetate and lipid-lowering therapy
  • Lipid-lowering therapy
  • Tucson, Arizona
  • +76 more
May 23, 2012

Type 2 Diabetes Trial in Mexico, Peru, United States (Colesevelam HCl)

Completed
  • Type 2 Diabetes
  • Colesevelam hydrochloride
  • Birmingham, Alabama
  • +46 more
Jan 16, 2012

Type 2 Diabetes Trial in United States (SK-0403, Placebo, Sitagliptin)

Completed
  • Type 2 Diabetes
  • Birmingham, Alabama
  • +39 more
Aug 15, 2011

Type 2 Diabetes Trial in Worldwide (Muraglitazar)

Completed
  • Type 2 Diabetes
  • Birmingham, Alabama
  • +84 more
Sep 10, 2010

Type 2 Diabetes Trial in Birmingham (Glucose potassium insulin solution)

Unknown status
  • Type 2 Diabetes
  • Glucose potassium insulin solution
  • Birmingham, West Midlands, United Kingdom
    University Hospital Birmingham
May 11, 2009

Type 2 Diabetes Trial in Worldwide (Tesaglitazar, Metformin)

Terminated
  • Type 2 Diabetes
  • Adelaide, Australia
  • +106 more
Apr 21, 2009

G-PLUS

Terminated
  • Type 2 Diabetes
    • Birmingham, Alabama
    • +542 more
    Mar 14, 2008

    Type 2 Diabetes Trial in Worldwide (tesaglitazar)

    Terminated
    • Type 2 Diabetes
    • Birmingham, Alabama
    • +276 more
    Mar 14, 2008

    Type 2 Diabetes Trial in Worldwide (Tesaglitazar 0.5 or 1 mg, Glibenclamide 2.5, 5, 10 or 15 mg)

    Terminated
    • Type 2 Diabetes
    • Tesaglitazar 0.5 or 1 mg
    • Glibenclamide 2.5, 5, 10 or 15 mg
    • Adelaide, Australia
    • +83 more
    Mar 14, 2008

    Type 2 Diabetes Trial in Mexico, Peru, United States (Colesevelam HCl)

    Completed
    • Type 2 Diabetes
    • Colesevelam hydrochloride
    • Birmingham, Alabama
    • +63 more
    Dec 26, 2007